SlideShare a Scribd company logo
1 of 75
Cytometry of Apoptosis Zbigniew Darzynkiewicz, M.D., Ph.D.  Brander Cancer Research Institute New York Medical College Hawthorne, NY 10536 [email_address] Detection of Mitochondrial Changes and Activation of Caspases and Serine proteases
HeNe laser LSC Optical System Scan Lens CCD Camera Objective Lens Computer Controlled  Stage  Scatter Sensor Scanning Mirror Dichroic Mirrors and  Optical Filters Photomultipliers Argon ion Laser Violet Diode Laser
Setting contours by LSC THRESHOLD CONTOUR INTEGRATION CONTOUR PERIPHERAL CONTOUR BACKGROUND CONTOUR nucleus cytoplasm
Parameters measured by LSC (I) ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Apoptosis - Falling off petals of the flower. Connotation of natural death Apoptosis:   Active cell death; “Cell suicide”   Necrosis:   Accidental cell death; “Cell murder”
Role of Cytometry in Analysis of Apoptosis  ,[object Object],[object Object],[object Object]
Morphology of apoptotic and   necrotic cells Apoptotic Reduced cell size Chromatin condensation Nuclear fragmentation Cell organelles unchanged Membrane “blebbing” Formation of apoptotic bodies Apoptotic bodies shed off Cell remnants phagocytized Cells detach from substrate Necrotic Cell and nuclear swelling Vacuolization of cytoplasm Patchy chromatin condensation Mitochondrial swelling Plasma membrane rupture Dissolution of chromatin Attraction of inflammatory cells
 
 
Confocal 3d images of nuclei from nonapoptotic (A) and apoptotic (B) cells stained with PI A B
HL-60 cells, Necrosis
Ca +2 Ca +2 Bad Raf-1 P Bad Bad Bad PT Pore Bax Conductance Pore Bag-1 AIF Bax Bax Bax Bax Bax Bax Bax CYTOCHROME   C RELEASE CASPASE-9 APAF-1 (CED-4) OLIGOMERIZATION of APAF-1 ATP, dATP ACTIVATION  OF CASPASE-9 “ Initiator caspase ” CARD ACTIVATED CASPASE-9 CASPASES-3,-6,-7 ACTIVATION  OF CASPASES INTRACELLULAR DEATH SIGNALS nucleus PARP PARP p53 Smac/DIABLO IAP Smac/DIABLO IAP Bcl-2 Bcl-X L Bcl-X L Bcl-2 Bcl-2 Bcl-2 Bcl-2
Main pathways of apoptosis Execution Cleavage of Apoptosis Regulators Cleavage of Housekeeping Proteins DNA Fragmentation Signals Death ligands (TNF, TRAIL) Internal cell stress, DNA damage Death Receptors Cytochrome C Release Caspase  a ctivator FADD Apaf-1 Bid Initiator  c aspase Caspase-8, Caspase-10 Caspase-9 Effector  c aspase Caspase-3, Caspase-6 or Caspase-7
Features of apoptosis measured by flow or laser scanning cytometry Plasma membrane   Change in permeability Change in asymmetry of phosphatidylserine Nucleus Chromatin condensation Nuclear fragmentation DNA fragmentation Organelles Change in mitochondrial membrane potential (  m ) Other features Caspase activation PARP cleavage Ser -proteases activation Transglutaminase 2 activation
LINKER DNA Apoptosis-induced DNA fragmentation HISTONE OCTAMER (NUCLEOSOME CORE) DNA ELECTROPHORESIS Distance between cuts = multiplicity of  200 base pairs 200 bp 400 bp 600 bp 800 bp ICAD CAD DNA cleavage
Indirect labeling of DNA breaks  dUTP -biotynylated TdT   TdT   avidin-FITC DNA cleavage ICAD CAD
Apoptotic  in situ  DNA  strand breaks
Colocalization: DNA and DNA strand breaks
Apoptosis – DNA strand breaks ,[object Object]
Apoptosis i n vivo; variablity in frequency of DNA strand breaks ,[object Object],[object Object],[object Object]
Early event of apoptosis: translocation of Bax to mitochondria Bcl-2 Bcl-X L Caspase 9 PARP PARP nucleus Bcl-X L -  Bcl 2 Bcl-2 Ca +2 Ca +2 Bad Raf-1 P Bad Bad Bad PT Pore Bax Conductance Pore p53 Caspase 3 Bag-1 Bcl-2 Bcl-2 APAF-1 AIF Cytochrome C Bax Bax Bax Bax Bax Bax Bax Bax Bax
Bax immunofluorescence, MCF-7 cells, CPT-treated
Translocation of Bax to mitochondria   N Bax in cytoplasm and in nucleus Bax in mitochondria C (diffuse) (punctate)
Translocation of Bax to mitochondria: Increase of maximal pixel of Bax immunofluorescence  DNA Content DNA Content DNA Content CTRL CPT 24h CPT 48h 150 150 150 0 0 0 G 1 S G 2 M Bax Max Pixel G 1 S G 2 M Bax max pixel DNA content
Dissipation of the mitochondrial trans- membrane electrochemical potential   Rhodamine 123 or carbo - cyanine dyes “ Aggregate” dyes (e.g. JC-1)
HL-60 CTRL HL-60 CPT 4h Rh 123 (rhodamine 123) Green Integral Green Integral Scatter Integral Scatter Integral
HL-60 CTRL HL-60 CPT 4h JC-1 (“aggregate” dye) (5,5’,6,6’-tetrachloro-1,1’,3,3’-tetraethylbenzimidazolcarbocyanine iodide) Green Integral Green Integral Orange Integral Orange Integral
Detection of caspases activation ,[object Object],[object Object],[object Object],[object Object]
Immunocytochemical detection of p-89 PARP
Immunocytochemical detection of PARP p89
PARP cleavage  vs  appearance of DNA strand breaks CPT-induced
PARP cleavage  vs  appearance of DNA strand breaks TNF-induced
PARP cleavage  vs  DNA strand break apperance
PARP cleavage  vs  appearance of DNA strand breaks
Is collapse of the mitochondrial potential a prerequisite for cytochrome c release ? Bcl-2 Bcl-X L Caspase 9 PARP PARP nucleus Bcl-X L -  Bcl 2 Bcl-2 Ca +2 Ca +2 Bad Raf-1 P Bad Bad Bad PT Pore Bax Conductance Pore p53 Caspase 3 Bag-1 Bcl-2 Bcl-2 APAF-1 AIF Cytochrome C Bax Bax Bax Bax Bax Bax Bax Bax Bax
Multiparameter analysis; cause - effect relationship A B A B ~100% B+ will be A+ some B+ will be A-
Cell attributes studied supravitally Cell attributes that require cell fixation  Integrity of plasma membrane Surface immuno-typing Phosphatidylserine on cell surface Transport through membrane Intracellular pH Oxidative stress (ROIs) Mitochondrial potential  Level of glutathione Activation of intracellular enzymes Calcium flux and other ions Cell cycle position, DNA ploidy BrdU incorporation DNA strand breaks Chromatin condensation Activation of NF-kappa B Bax, cytochrome c translocations Translocation of other (AIF, APAF-1) molecules Caspase activation (e.g. PARP cleavage) Immunodetection of intracellular proteins Changes in cell morphology
Strategy to detect correlation between the paramaters measured on live (mitochondrial potential)  vs  fixed (PARP cleavage) cells  by LSC  Live cells Measure   m Fix cells   Measure PARP File # 1 File # 2 Merge file # 1  and # 2 Analyze the merged file
Mitochondrial potential  vs  PARP cleavage
Fl uorochrome-labeled  i nhibitors of  ca spasses FLICA Affinity labeling probes of caspase enzymatic center FAM FMK VEID
INACTIVE CASPASE (ZYMOGEN) ACTIVATED CASPASE (HETERO-TETRAMER) BINDING OF FLICA prodomain A B C D FLICA Active center Active center FAM FMK VEID
FAM-DEVD-FMK
VAD CTRL CPT 3H CPT 4H VEID TNF+CHX 1h TNF+CHX 1.5h VAD CTRL
PI - fluorescence FAM-VAD-FMK 100 0 10 4 PI - fluorescence FAM-VAD-FMK 100 0 10 4 FAM-VAD-FMK FAM-VAD-FMK 100 100 Number of cells Number of cells 0 0 Control Control 3h CPT 3h CPT D C A B Caspases activation during apoptosis induced by CPT
Green Max Pixel Cell frequency 0 100 100 1 2 Protection of FAM-VAD-FMK binding  by cell pre-exposure to z-VAD-FMK
A B Caspases activation detected by FAM-VAD-FMK binding
FAM-VAD-FMK binding; fixed cells
Concurrent cell staining with FAM-VAD-FMK and PI FAM-VAD-FMK fluorescence PI fluorescence
Time (h) control 2h 3h  4h  5h A B C D B A D C Cell number (%) P  I  f  l  u  o  r  e  s  c  e  n  c  e 100 0 10 4 10 4 10 4 10 4 10 4 0  2  3  4  5 100 FAM-VAD-FMK fluorescence 0 0 0 0 0 100 100 100 100 Kinetics of FAM-VAD-FMK and PI binding
Caspase activation - cell cycle specificity   Effect of TNF on HL-60 cells  PI, INT FAM-VAD-FMK; MPX 0 a b 10 3 10 3 100 100 0  FAM-VAD-FMK; INT FAM-VAD-FMK; INT G 1 S G 2 /M
A B C D Propidium Iodide FAM-VAD-FMK Distinction between apoptotic and necrotic cells based on caspases activation (FAM-VAD-FMK binding)  vs  exclusion of PI  Ctr Parthenolide -treated HL-60 cells
Correlation between caspase activation and Annexin V binding  Annexin V, Max Pix FAM-VAD-FMK, Max Pix Annexin V, Max Pix
Stathmo-apoptosis; arresting progress of apoptotic process Not arrested Arrested FAM-VAD-FMK fluorescence P  I  f  l  u  o  r  e  s  c  e  n  c  e P  I  f  l  u  o  r  e  s  c  e  n  c  e FAM-VAD-FMK fluorescence FAM-VAD-FMK fluorescence FAM-VAD-FMK fluorescence FAM-VAD-FMK fluorescence 100 100 100 100 100 0 0 0 0 0 10 4 10 4 10 4 10 4 10 4 3 % 2 % 4 % 9 % 21 % 20 % 25 % 2 % 2 % 2 % 9 % 7 % 51% 10 % 2 % 6h 3h
Stathmo-apoptosis ARRESTED NOT ARRESTED A B C D FAM-VAD-FMK 10 4 10 4 0 Propidium iodide Control A C D P r o p i d i u m  i o d i d e B FAM-VAD-FMK 10 4 10 4 0 10 4 10 4 0 10 4 10 4 0 FAM-VAD-FMK 10 4 10 4 0 TNF  FLICA TNF +  FLICA CPT +  FLICA CPT  FLICA
FAM-VAD-FMK fluorescence 10 0  Stathmo-apoptosis Apoptotic MCF 7 cells prevented from detachment   48h 72h Control Ap-1% Ap-13% Ap-23% Ap-39% Ap-24% P  I  f  l  u  o  r  e  s  c  e  n  c  e 0  0  FAM-VAD-FMK fluorescence FAM-VAD-FMK fluorescence 0 0 10 2 0  FAM -VAD -FMK fluorescence FAM-VAD-FMK fluorescence 10 2 10 2 10 2 10 2 P  I  f  l  u  o  r  e  s  c  e  n  c  e 10 0  10 0  10 0  10 0
Activation-induced apoptosis of lymphocytes Caspases activation detected by FLICA PI fluorescence FAM-VAD-FMK CTR PHA PHA+ONC A A D A B B B D D C C C A B C D
0  24  48  72 0 0 Time (h) 40 40 0 0 60 60 0 60 Time (h) CAI (%) CAI (%) CAI (%) Patient 1 Patient 2 Patient 3 Patient 4 0  24  48  72 0  24  48  72 0  24  48  72 0  24  48  72 Patient 5 2-CdA Control Subtracted CAI
Detection of serine-proteases activation ,[object Object],[object Object]
FLISP (Fluorochrome-labeled inhibitor of  Ser -proteases) Labeling of active enzyme center of  Ser -proteases with FLISP Asp-102 His-57 Ser-195 FAM F (Phe) CMK Imidazole Alkylated imidazole   Active chymotrypsin Covalent binding of FLISP
CPT-induced apoptosis of T-24 cells -  Texas Red-FCK vs DAPI
    Propidium iodide   10 4 10 4 10 4 10 4 FFCK FFCK FLCK FLCK FFCK FLCK FFCK FLCK 100 100 100 100 100 100 100 100 0 0 0 0 Control 3h   CPT Control Control Control 3h CPT 3h CPT 3h CPT Number of cells 0 0 0 0 Activation of  Ser -proteases reactive with FFCK and FLCK during apoptosis of HL-60 cells induced by CPT
SR-VAD-FMK 100 0 FFCK 0 100 r = 0.72 Activation of  caspases  and  Ser -protease(s) ( FFCK -reactive) in HL- 60 cells 3 h after addition of CPT
Activation of caspases and Ser-proteases   SR-VAD-FMK   / FFCK
FLCK SR-VAD-FMK 100 0 100 r = 0.82 Activation of caspases and  Ser -protease(s) ( FLCK -reactive) in HL- 60 cells 3 h after addition of CPT
FAM-VAD-FMK FFCK r = 0.98 FLCK FAM-VAD-FMK r = 0.982 Correlation between activation of caspases (FAM-VAD-FMK) and  Ser -proteases during apoptosis of HL-60 cells induced by CPT r = 0.986
SR-VAD-FMK (Int) FFCK (Int) 0 100 SR-VAD-FMK (Int) FFCK (Int) 0 100 100 100 100 0 Apoptosis of HL-60 cells  induced by Onconase FFCK vs SR-VAD-FMK binding   Ctrl Onc
100 SR-VAD-FMK (Int) FLCK (Int) 0 100 100 SR-VAD-FMK (Int) FLCK (Int) 0 100 100 Apoptosis of HL-60 cells induced by Onconase FLCK vs FAM-VAD-FMK binding
Activation of caspases and Ser-proteases during apoptosis  of HL-60 cells induced by Onconase PI fluorescence  FAM-VAD-FMK FFCK FLCK Ctrl Ctrl Ctrl Onc Onc Onc
Proteins covalently reactive with FFCK and FLCK (anti-fluorescein Ab) 205 112 70 52.4 Control FFCK FFCK+TNF Control FLCK FLCK+TNF
Brander Cancer Research Institute at NYMC, Valhalla, NY E. Bedner W. Gorczyca J. Grabarek  G. Juan X. Li P. Pozarowski P. Smolewski F. Traganos Z. Darzynkiewicz Immunochemistry Technologies, Bloomington NM B.W. Lee G. Johnson
Activation of transglutaminase  Tissue transglutaminase 2 (TGase 2) G-protein signalling; protein crosslinking ,[object Object],[object Object]
A B C D * * * * * * * * TGase 2 Resistance to detergent (A,B) Fluorescein-cadaverine binding (C,D)
SULFORHODAMINE (protein) 100 100 0 A D 100 100 0 C 100 100 0 B G 1 G 2 M S DAPI; DNA content TGase 2, cell resistance to detergent
FL - cadaverine DNA content 100 0 100 FL - cadaverine DNA content 100 0 100 G 1 G 2 M S TGase 2; binding of fluoresceinated cadaverine
FAM-VAD-FCK  vs  PI   FFCK  vs  PI FLCK  vs  PI

More Related Content

What's hot (20)

Apaptosis
Apaptosis Apaptosis
Apaptosis
 
Apoptosis my ppt
Apoptosis my pptApoptosis my ppt
Apoptosis my ppt
 
Apoptosis
ApoptosisApoptosis
Apoptosis
 
Apoptosis continued
Apoptosis continuedApoptosis continued
Apoptosis continued
 
Apoptosis
ApoptosisApoptosis
Apoptosis
 
Apoptosis
ApoptosisApoptosis
Apoptosis
 
Apoptosis
ApoptosisApoptosis
Apoptosis
 
Apoptosis
ApoptosisApoptosis
Apoptosis
 
Apoptosis and neurological disorders
Apoptosis and neurological disordersApoptosis and neurological disorders
Apoptosis and neurological disorders
 
Apoptosis
ApoptosisApoptosis
Apoptosis
 
Apoptosis
ApoptosisApoptosis
Apoptosis
 
Apoptosis
ApoptosisApoptosis
Apoptosis
 
Apoptosis
ApoptosisApoptosis
Apoptosis
 
Apoptosis
ApoptosisApoptosis
Apoptosis
 
Apoptosis seminar f
Apoptosis seminar fApoptosis seminar f
Apoptosis seminar f
 
Advances in apoptotic pathways
Advances in apoptotic pathwaysAdvances in apoptotic pathways
Advances in apoptotic pathways
 
Apoptosis: Programmed Cell Death
Apoptosis: Programmed Cell DeathApoptosis: Programmed Cell Death
Apoptosis: Programmed Cell Death
 
PROGRAMMED CELL DEATH
PROGRAMMED CELL DEATHPROGRAMMED CELL DEATH
PROGRAMMED CELL DEATH
 
Apoptosis / dental crown & bridge courses
Apoptosis / dental crown & bridge coursesApoptosis / dental crown & bridge courses
Apoptosis / dental crown & bridge courses
 
Apoptosis
ApoptosisApoptosis
Apoptosis
 

Similar to Apoptosis

A Sub-network of Signaling Protein Complexes in AA May Provide New Molecular ...
A Sub-network of Signaling Protein Complexes in AA May Provide New Molecular ...A Sub-network of Signaling Protein Complexes in AA May Provide New Molecular ...
A Sub-network of Signaling Protein Complexes in AA May Provide New Molecular ...National Alopecia Areata Foundation
 
Western Blotting Of Camkii Β And T 287
Western Blotting Of Camkii Β And T 287Western Blotting Of Camkii Β And T 287
Western Blotting Of Camkii Β And T 287Beth Salazar
 
in vitro radiosenstization of PDAC through FAK inhibition
in vitro radiosenstization of PDAC through FAK inhibition in vitro radiosenstization of PDAC through FAK inhibition
in vitro radiosenstization of PDAC through FAK inhibition Ahmed Allam
 
Real-time PCR.ppt
Real-time PCR.pptReal-time PCR.ppt
Real-time PCR.pptSappahAhmed
 
Neurotech seminar ish wish 2014 maduna
Neurotech seminar ish wish 2014 madunaNeurotech seminar ish wish 2014 maduna
Neurotech seminar ish wish 2014 madunaTando Maduna
 
20081216 05袁國芳 紅麴菌基因體計畫及基因研究
20081216 05袁國芳 紅麴菌基因體計畫及基因研究20081216 05袁國芳 紅麴菌基因體計畫及基因研究
20081216 05袁國芳 紅麴菌基因體計畫及基因研究Monascus2008
 
antigen presentation machinery in ctcs (1)
antigen presentation machinery in ctcs (1)antigen presentation machinery in ctcs (1)
antigen presentation machinery in ctcs (1)Stephanie Thiede
 
New-gene manipulication class -xs 2023-课件1(周一).pdf
New-gene manipulication class -xs 2023-课件1(周一).pdfNew-gene manipulication class -xs 2023-课件1(周一).pdf
New-gene manipulication class -xs 2023-课件1(周一).pdfssuser13f50b1
 
20081216 06陳倩琪 紅麴菌基因體之定序與分析
20081216 06陳倩琪 紅麴菌基因體之定序與分析20081216 06陳倩琪 紅麴菌基因體之定序與分析
20081216 06陳倩琪 紅麴菌基因體之定序與分析Monascus2008
 
Making genome edits in mammalian cells
Making genome edits in mammalian cellsMaking genome edits in mammalian cells
Making genome edits in mammalian cellsChris Thorne
 
Circulating Cell Free DNA Targeted Sequencing Workflow | ESHG 2015 Poster PM1...
Circulating Cell Free DNA Targeted Sequencing Workflow | ESHG 2015 Poster PM1...Circulating Cell Free DNA Targeted Sequencing Workflow | ESHG 2015 Poster PM1...
Circulating Cell Free DNA Targeted Sequencing Workflow | ESHG 2015 Poster PM1...Thermo Fisher Scientific
 
Pathway map-reference-guide
Pathway map-reference-guidePathway map-reference-guide
Pathway map-reference-guideElsa von Licy
 
Varda Rotter - Weizmann Institute of Science.
Varda Rotter - Weizmann Institute of Science.Varda Rotter - Weizmann Institute of Science.
Varda Rotter - Weizmann Institute of Science.Fundación Ramón Areces
 

Similar to Apoptosis (20)

Ap2 Alpha
Ap2 AlphaAp2 Alpha
Ap2 Alpha
 
KL PhD Presentation
KL PhD PresentationKL PhD Presentation
KL PhD Presentation
 
A Sub-network of Signaling Protein Complexes in AA May Provide New Molecular ...
A Sub-network of Signaling Protein Complexes in AA May Provide New Molecular ...A Sub-network of Signaling Protein Complexes in AA May Provide New Molecular ...
A Sub-network of Signaling Protein Complexes in AA May Provide New Molecular ...
 
Western Blotting Of Camkii Β And T 287
Western Blotting Of Camkii Β And T 287Western Blotting Of Camkii Β And T 287
Western Blotting Of Camkii Β And T 287
 
in vitro radiosenstization of PDAC through FAK inhibition
in vitro radiosenstization of PDAC through FAK inhibition in vitro radiosenstization of PDAC through FAK inhibition
in vitro radiosenstization of PDAC through FAK inhibition
 
Real-time PCR.ppt
Real-time PCR.pptReal-time PCR.ppt
Real-time PCR.ppt
 
Neurotech seminar ish wish 2014 maduna
Neurotech seminar ish wish 2014 madunaNeurotech seminar ish wish 2014 maduna
Neurotech seminar ish wish 2014 maduna
 
20081216 05袁國芳 紅麴菌基因體計畫及基因研究
20081216 05袁國芳 紅麴菌基因體計畫及基因研究20081216 05袁國芳 紅麴菌基因體計畫及基因研究
20081216 05袁國芳 紅麴菌基因體計畫及基因研究
 
antigen presentation machinery in ctcs (1)
antigen presentation machinery in ctcs (1)antigen presentation machinery in ctcs (1)
antigen presentation machinery in ctcs (1)
 
GKA deel 1 college 11
GKA deel 1 college 11GKA deel 1 college 11
GKA deel 1 college 11
 
New-gene manipulication class -xs 2023-课件1(周一).pdf
New-gene manipulication class -xs 2023-课件1(周一).pdfNew-gene manipulication class -xs 2023-课件1(周一).pdf
New-gene manipulication class -xs 2023-课件1(周一).pdf
 
20081216 06陳倩琪 紅麴菌基因體之定序與分析
20081216 06陳倩琪 紅麴菌基因體之定序與分析20081216 06陳倩琪 紅麴菌基因體之定序與分析
20081216 06陳倩琪 紅麴菌基因體之定序與分析
 
Making genome edits in mammalian cells
Making genome edits in mammalian cellsMaking genome edits in mammalian cells
Making genome edits in mammalian cells
 
Honors ~ DNA 1011
Honors ~ DNA 1011Honors ~ DNA 1011
Honors ~ DNA 1011
 
Circulating Cell Free DNA Targeted Sequencing Workflow | ESHG 2015 Poster PM1...
Circulating Cell Free DNA Targeted Sequencing Workflow | ESHG 2015 Poster PM1...Circulating Cell Free DNA Targeted Sequencing Workflow | ESHG 2015 Poster PM1...
Circulating Cell Free DNA Targeted Sequencing Workflow | ESHG 2015 Poster PM1...
 
Pathway map-reference-guide
Pathway map-reference-guidePathway map-reference-guide
Pathway map-reference-guide
 
Mb cell death-apoptosis
Mb cell death-apoptosisMb cell death-apoptosis
Mb cell death-apoptosis
 
Varda Rotter - Weizmann Institute of Science.
Varda Rotter - Weizmann Institute of Science.Varda Rotter - Weizmann Institute of Science.
Varda Rotter - Weizmann Institute of Science.
 
Disease 2010 poster-final
Disease 2010 poster-finalDisease 2010 poster-final
Disease 2010 poster-final
 
Ponencia Agustin Zapata GonzáLez Pescando Genes Santander UIMP 2008
Ponencia Agustin Zapata GonzáLez Pescando Genes Santander UIMP 2008Ponencia Agustin Zapata GonzáLez Pescando Genes Santander UIMP 2008
Ponencia Agustin Zapata GonzáLez Pescando Genes Santander UIMP 2008
 

More from Pete Shuster

Neuromics' Short Overview
Neuromics' Short OverviewNeuromics' Short Overview
Neuromics' Short OverviewPete Shuster
 
Neuromics presentation november 2021
Neuromics presentation november 2021Neuromics presentation november 2021
Neuromics presentation november 2021Pete Shuster
 
Neuromics Bases 2 and 3 Cell Based Assays
Neuromics Bases 2 and 3 Cell Based AssaysNeuromics Bases 2 and 3 Cell Based Assays
Neuromics Bases 2 and 3 Cell Based AssaysPete Shuster
 
2 and 3-D Human Cell-Based Assays
2 and 3-D Human Cell-Based Assays2 and 3-D Human Cell-Based Assays
2 and 3-D Human Cell-Based AssaysPete Shuster
 
Neuromics base presentation 2020 with Virus Transport Media
Neuromics base presentation 2020 with Virus Transport MediaNeuromics base presentation 2020 with Virus Transport Media
Neuromics base presentation 2020 with Virus Transport MediaPete Shuster
 
Neuromics base presentation 2020
Neuromics base presentation 2020Neuromics base presentation 2020
Neuromics base presentation 2020Pete Shuster
 
Neuromics base presentation 2019
Neuromics base presentation 2019Neuromics base presentation 2019
Neuromics base presentation 2019Pete Shuster
 
Human blood brain barrier
Human blood brain barrierHuman blood brain barrier
Human blood brain barrierPete Shuster
 
"Bedside to Bench" in Drug Discovery
"Bedside to Bench" in Drug Discovery"Bedside to Bench" in Drug Discovery
"Bedside to Bench" in Drug DiscoveryPete Shuster
 
Poster sot 2015_am_final
Poster sot 2015_am_finalPoster sot 2015_am_final
Poster sot 2015_am_finalPete Shuster
 
CELL-a-brate-Knowing Your Assays
CELL-a-brate-Knowing Your AssaysCELL-a-brate-Knowing Your Assays
CELL-a-brate-Knowing Your AssaysPete Shuster
 
Regenerative Medicine Industry Outlook 2014
Regenerative Medicine Industry Outlook 2014Regenerative Medicine Industry Outlook 2014
Regenerative Medicine Industry Outlook 2014Pete Shuster
 
Vitro Biopharma-Business & technical overview 12 9-13
Vitro Biopharma-Business & technical overview 12 9-13Vitro Biopharma-Business & technical overview 12 9-13
Vitro Biopharma-Business & technical overview 12 9-13Pete Shuster
 
Neuron Glial Interactions
Neuron Glial InteractionsNeuron Glial Interactions
Neuron Glial InteractionsPete Shuster
 
Optimized Protocol for Sorting Cells
Optimized Protocol for Sorting CellsOptimized Protocol for Sorting Cells
Optimized Protocol for Sorting CellsPete Shuster
 
Biopharma musculoskeletal disorders_draft 6-30-2013 jm edits
Biopharma musculoskeletal disorders_draft 6-30-2013 jm editsBiopharma musculoskeletal disorders_draft 6-30-2013 jm edits
Biopharma musculoskeletal disorders_draft 6-30-2013 jm editsPete Shuster
 
Biopharma musculoskeletal disorders_4-30-2013
Biopharma musculoskeletal disorders_4-30-2013Biopharma musculoskeletal disorders_4-30-2013
Biopharma musculoskeletal disorders_4-30-2013Pete Shuster
 
Cell based assays presentation v3_03_2012
Cell based assays presentation v3_03_2012Cell based assays presentation v3_03_2012
Cell based assays presentation v3_03_2012Pete Shuster
 
Cell based assays presentation V2_03_2012
Cell based assays presentation V2_03_2012Cell based assays presentation V2_03_2012
Cell based assays presentation V2_03_2012Pete Shuster
 
Essen bioscience neuromics 9_17_12
Essen bioscience neuromics 9_17_12Essen bioscience neuromics 9_17_12
Essen bioscience neuromics 9_17_12Pete Shuster
 

More from Pete Shuster (20)

Neuromics' Short Overview
Neuromics' Short OverviewNeuromics' Short Overview
Neuromics' Short Overview
 
Neuromics presentation november 2021
Neuromics presentation november 2021Neuromics presentation november 2021
Neuromics presentation november 2021
 
Neuromics Bases 2 and 3 Cell Based Assays
Neuromics Bases 2 and 3 Cell Based AssaysNeuromics Bases 2 and 3 Cell Based Assays
Neuromics Bases 2 and 3 Cell Based Assays
 
2 and 3-D Human Cell-Based Assays
2 and 3-D Human Cell-Based Assays2 and 3-D Human Cell-Based Assays
2 and 3-D Human Cell-Based Assays
 
Neuromics base presentation 2020 with Virus Transport Media
Neuromics base presentation 2020 with Virus Transport MediaNeuromics base presentation 2020 with Virus Transport Media
Neuromics base presentation 2020 with Virus Transport Media
 
Neuromics base presentation 2020
Neuromics base presentation 2020Neuromics base presentation 2020
Neuromics base presentation 2020
 
Neuromics base presentation 2019
Neuromics base presentation 2019Neuromics base presentation 2019
Neuromics base presentation 2019
 
Human blood brain barrier
Human blood brain barrierHuman blood brain barrier
Human blood brain barrier
 
"Bedside to Bench" in Drug Discovery
"Bedside to Bench" in Drug Discovery"Bedside to Bench" in Drug Discovery
"Bedside to Bench" in Drug Discovery
 
Poster sot 2015_am_final
Poster sot 2015_am_finalPoster sot 2015_am_final
Poster sot 2015_am_final
 
CELL-a-brate-Knowing Your Assays
CELL-a-brate-Knowing Your AssaysCELL-a-brate-Knowing Your Assays
CELL-a-brate-Knowing Your Assays
 
Regenerative Medicine Industry Outlook 2014
Regenerative Medicine Industry Outlook 2014Regenerative Medicine Industry Outlook 2014
Regenerative Medicine Industry Outlook 2014
 
Vitro Biopharma-Business & technical overview 12 9-13
Vitro Biopharma-Business & technical overview 12 9-13Vitro Biopharma-Business & technical overview 12 9-13
Vitro Biopharma-Business & technical overview 12 9-13
 
Neuron Glial Interactions
Neuron Glial InteractionsNeuron Glial Interactions
Neuron Glial Interactions
 
Optimized Protocol for Sorting Cells
Optimized Protocol for Sorting CellsOptimized Protocol for Sorting Cells
Optimized Protocol for Sorting Cells
 
Biopharma musculoskeletal disorders_draft 6-30-2013 jm edits
Biopharma musculoskeletal disorders_draft 6-30-2013 jm editsBiopharma musculoskeletal disorders_draft 6-30-2013 jm edits
Biopharma musculoskeletal disorders_draft 6-30-2013 jm edits
 
Biopharma musculoskeletal disorders_4-30-2013
Biopharma musculoskeletal disorders_4-30-2013Biopharma musculoskeletal disorders_4-30-2013
Biopharma musculoskeletal disorders_4-30-2013
 
Cell based assays presentation v3_03_2012
Cell based assays presentation v3_03_2012Cell based assays presentation v3_03_2012
Cell based assays presentation v3_03_2012
 
Cell based assays presentation V2_03_2012
Cell based assays presentation V2_03_2012Cell based assays presentation V2_03_2012
Cell based assays presentation V2_03_2012
 
Essen bioscience neuromics 9_17_12
Essen bioscience neuromics 9_17_12Essen bioscience neuromics 9_17_12
Essen bioscience neuromics 9_17_12
 

Recently uploaded

Salesforce Community Group Quito, Salesforce 101
Salesforce Community Group Quito, Salesforce 101Salesforce Community Group Quito, Salesforce 101
Salesforce Community Group Quito, Salesforce 101Paola De la Torre
 
Strategies for Unlocking Knowledge Management in Microsoft 365 in the Copilot...
Strategies for Unlocking Knowledge Management in Microsoft 365 in the Copilot...Strategies for Unlocking Knowledge Management in Microsoft 365 in the Copilot...
Strategies for Unlocking Knowledge Management in Microsoft 365 in the Copilot...Drew Madelung
 
Automating Google Workspace (GWS) & more with Apps Script
Automating Google Workspace (GWS) & more with Apps ScriptAutomating Google Workspace (GWS) & more with Apps Script
Automating Google Workspace (GWS) & more with Apps Scriptwesley chun
 
EIS-Webinar-Prompt-Knowledge-Eng-2024-04-08.pptx
EIS-Webinar-Prompt-Knowledge-Eng-2024-04-08.pptxEIS-Webinar-Prompt-Knowledge-Eng-2024-04-08.pptx
EIS-Webinar-Prompt-Knowledge-Eng-2024-04-08.pptxEarley Information Science
 
Driving Behavioral Change for Information Management through Data-Driven Gree...
Driving Behavioral Change for Information Management through Data-Driven Gree...Driving Behavioral Change for Information Management through Data-Driven Gree...
Driving Behavioral Change for Information Management through Data-Driven Gree...Enterprise Knowledge
 
Developing An App To Navigate The Roads of Brazil
Developing An App To Navigate The Roads of BrazilDeveloping An App To Navigate The Roads of Brazil
Developing An App To Navigate The Roads of BrazilV3cube
 
Presentation on how to chat with PDF using ChatGPT code interpreter
Presentation on how to chat with PDF using ChatGPT code interpreterPresentation on how to chat with PDF using ChatGPT code interpreter
Presentation on how to chat with PDF using ChatGPT code interpreternaman860154
 
Raspberry Pi 5: Challenges and Solutions in Bringing up an OpenGL/Vulkan Driv...
Raspberry Pi 5: Challenges and Solutions in Bringing up an OpenGL/Vulkan Driv...Raspberry Pi 5: Challenges and Solutions in Bringing up an OpenGL/Vulkan Driv...
Raspberry Pi 5: Challenges and Solutions in Bringing up an OpenGL/Vulkan Driv...Igalia
 
Data Cloud, More than a CDP by Matt Robison
Data Cloud, More than a CDP by Matt RobisonData Cloud, More than a CDP by Matt Robison
Data Cloud, More than a CDP by Matt RobisonAnna Loughnan Colquhoun
 
A Call to Action for Generative AI in 2024
A Call to Action for Generative AI in 2024A Call to Action for Generative AI in 2024
A Call to Action for Generative AI in 2024Results
 
The 7 Things I Know About Cyber Security After 25 Years | April 2024
The 7 Things I Know About Cyber Security After 25 Years | April 2024The 7 Things I Know About Cyber Security After 25 Years | April 2024
The 7 Things I Know About Cyber Security After 25 Years | April 2024Rafal Los
 
From Event to Action: Accelerate Your Decision Making with Real-Time Automation
From Event to Action: Accelerate Your Decision Making with Real-Time AutomationFrom Event to Action: Accelerate Your Decision Making with Real-Time Automation
From Event to Action: Accelerate Your Decision Making with Real-Time AutomationSafe Software
 
Kalyanpur ) Call Girls in Lucknow Finest Escorts Service 🍸 8923113531 🎰 Avail...
Kalyanpur ) Call Girls in Lucknow Finest Escorts Service 🍸 8923113531 🎰 Avail...Kalyanpur ) Call Girls in Lucknow Finest Escorts Service 🍸 8923113531 🎰 Avail...
Kalyanpur ) Call Girls in Lucknow Finest Escorts Service 🍸 8923113531 🎰 Avail...gurkirankumar98700
 
Neo4j - How KGs are shaping the future of Generative AI at AWS Summit London ...
Neo4j - How KGs are shaping the future of Generative AI at AWS Summit London ...Neo4j - How KGs are shaping the future of Generative AI at AWS Summit London ...
Neo4j - How KGs are shaping the future of Generative AI at AWS Summit London ...Neo4j
 
Finology Group – Insurtech Innovation Award 2024
Finology Group – Insurtech Innovation Award 2024Finology Group – Insurtech Innovation Award 2024
Finology Group – Insurtech Innovation Award 2024The Digital Insurer
 
Slack Application Development 101 Slides
Slack Application Development 101 SlidesSlack Application Development 101 Slides
Slack Application Development 101 Slidespraypatel2
 
04-2024-HHUG-Sales-and-Marketing-Alignment.pptx
04-2024-HHUG-Sales-and-Marketing-Alignment.pptx04-2024-HHUG-Sales-and-Marketing-Alignment.pptx
04-2024-HHUG-Sales-and-Marketing-Alignment.pptxHampshireHUG
 
🐬 The future of MySQL is Postgres 🐘
🐬  The future of MySQL is Postgres   🐘🐬  The future of MySQL is Postgres   🐘
🐬 The future of MySQL is Postgres 🐘RTylerCroy
 
[2024]Digital Global Overview Report 2024 Meltwater.pdf
[2024]Digital Global Overview Report 2024 Meltwater.pdf[2024]Digital Global Overview Report 2024 Meltwater.pdf
[2024]Digital Global Overview Report 2024 Meltwater.pdfhans926745
 
GenCyber Cyber Security Day Presentation
GenCyber Cyber Security Day PresentationGenCyber Cyber Security Day Presentation
GenCyber Cyber Security Day PresentationMichael W. Hawkins
 

Recently uploaded (20)

Salesforce Community Group Quito, Salesforce 101
Salesforce Community Group Quito, Salesforce 101Salesforce Community Group Quito, Salesforce 101
Salesforce Community Group Quito, Salesforce 101
 
Strategies for Unlocking Knowledge Management in Microsoft 365 in the Copilot...
Strategies for Unlocking Knowledge Management in Microsoft 365 in the Copilot...Strategies for Unlocking Knowledge Management in Microsoft 365 in the Copilot...
Strategies for Unlocking Knowledge Management in Microsoft 365 in the Copilot...
 
Automating Google Workspace (GWS) & more with Apps Script
Automating Google Workspace (GWS) & more with Apps ScriptAutomating Google Workspace (GWS) & more with Apps Script
Automating Google Workspace (GWS) & more with Apps Script
 
EIS-Webinar-Prompt-Knowledge-Eng-2024-04-08.pptx
EIS-Webinar-Prompt-Knowledge-Eng-2024-04-08.pptxEIS-Webinar-Prompt-Knowledge-Eng-2024-04-08.pptx
EIS-Webinar-Prompt-Knowledge-Eng-2024-04-08.pptx
 
Driving Behavioral Change for Information Management through Data-Driven Gree...
Driving Behavioral Change for Information Management through Data-Driven Gree...Driving Behavioral Change for Information Management through Data-Driven Gree...
Driving Behavioral Change for Information Management through Data-Driven Gree...
 
Developing An App To Navigate The Roads of Brazil
Developing An App To Navigate The Roads of BrazilDeveloping An App To Navigate The Roads of Brazil
Developing An App To Navigate The Roads of Brazil
 
Presentation on how to chat with PDF using ChatGPT code interpreter
Presentation on how to chat with PDF using ChatGPT code interpreterPresentation on how to chat with PDF using ChatGPT code interpreter
Presentation on how to chat with PDF using ChatGPT code interpreter
 
Raspberry Pi 5: Challenges and Solutions in Bringing up an OpenGL/Vulkan Driv...
Raspberry Pi 5: Challenges and Solutions in Bringing up an OpenGL/Vulkan Driv...Raspberry Pi 5: Challenges and Solutions in Bringing up an OpenGL/Vulkan Driv...
Raspberry Pi 5: Challenges and Solutions in Bringing up an OpenGL/Vulkan Driv...
 
Data Cloud, More than a CDP by Matt Robison
Data Cloud, More than a CDP by Matt RobisonData Cloud, More than a CDP by Matt Robison
Data Cloud, More than a CDP by Matt Robison
 
A Call to Action for Generative AI in 2024
A Call to Action for Generative AI in 2024A Call to Action for Generative AI in 2024
A Call to Action for Generative AI in 2024
 
The 7 Things I Know About Cyber Security After 25 Years | April 2024
The 7 Things I Know About Cyber Security After 25 Years | April 2024The 7 Things I Know About Cyber Security After 25 Years | April 2024
The 7 Things I Know About Cyber Security After 25 Years | April 2024
 
From Event to Action: Accelerate Your Decision Making with Real-Time Automation
From Event to Action: Accelerate Your Decision Making with Real-Time AutomationFrom Event to Action: Accelerate Your Decision Making with Real-Time Automation
From Event to Action: Accelerate Your Decision Making with Real-Time Automation
 
Kalyanpur ) Call Girls in Lucknow Finest Escorts Service 🍸 8923113531 🎰 Avail...
Kalyanpur ) Call Girls in Lucknow Finest Escorts Service 🍸 8923113531 🎰 Avail...Kalyanpur ) Call Girls in Lucknow Finest Escorts Service 🍸 8923113531 🎰 Avail...
Kalyanpur ) Call Girls in Lucknow Finest Escorts Service 🍸 8923113531 🎰 Avail...
 
Neo4j - How KGs are shaping the future of Generative AI at AWS Summit London ...
Neo4j - How KGs are shaping the future of Generative AI at AWS Summit London ...Neo4j - How KGs are shaping the future of Generative AI at AWS Summit London ...
Neo4j - How KGs are shaping the future of Generative AI at AWS Summit London ...
 
Finology Group – Insurtech Innovation Award 2024
Finology Group – Insurtech Innovation Award 2024Finology Group – Insurtech Innovation Award 2024
Finology Group – Insurtech Innovation Award 2024
 
Slack Application Development 101 Slides
Slack Application Development 101 SlidesSlack Application Development 101 Slides
Slack Application Development 101 Slides
 
04-2024-HHUG-Sales-and-Marketing-Alignment.pptx
04-2024-HHUG-Sales-and-Marketing-Alignment.pptx04-2024-HHUG-Sales-and-Marketing-Alignment.pptx
04-2024-HHUG-Sales-and-Marketing-Alignment.pptx
 
🐬 The future of MySQL is Postgres 🐘
🐬  The future of MySQL is Postgres   🐘🐬  The future of MySQL is Postgres   🐘
🐬 The future of MySQL is Postgres 🐘
 
[2024]Digital Global Overview Report 2024 Meltwater.pdf
[2024]Digital Global Overview Report 2024 Meltwater.pdf[2024]Digital Global Overview Report 2024 Meltwater.pdf
[2024]Digital Global Overview Report 2024 Meltwater.pdf
 
GenCyber Cyber Security Day Presentation
GenCyber Cyber Security Day PresentationGenCyber Cyber Security Day Presentation
GenCyber Cyber Security Day Presentation
 

Apoptosis

  • 1. Cytometry of Apoptosis Zbigniew Darzynkiewicz, M.D., Ph.D. Brander Cancer Research Institute New York Medical College Hawthorne, NY 10536 [email_address] Detection of Mitochondrial Changes and Activation of Caspases and Serine proteases
  • 2. HeNe laser LSC Optical System Scan Lens CCD Camera Objective Lens Computer Controlled Stage Scatter Sensor Scanning Mirror Dichroic Mirrors and Optical Filters Photomultipliers Argon ion Laser Violet Diode Laser
  • 3. Setting contours by LSC THRESHOLD CONTOUR INTEGRATION CONTOUR PERIPHERAL CONTOUR BACKGROUND CONTOUR nucleus cytoplasm
  • 4.
  • 5. Apoptosis - Falling off petals of the flower. Connotation of natural death Apoptosis: Active cell death; “Cell suicide” Necrosis: Accidental cell death; “Cell murder”
  • 6.
  • 7. Morphology of apoptotic and necrotic cells Apoptotic Reduced cell size Chromatin condensation Nuclear fragmentation Cell organelles unchanged Membrane “blebbing” Formation of apoptotic bodies Apoptotic bodies shed off Cell remnants phagocytized Cells detach from substrate Necrotic Cell and nuclear swelling Vacuolization of cytoplasm Patchy chromatin condensation Mitochondrial swelling Plasma membrane rupture Dissolution of chromatin Attraction of inflammatory cells
  • 8.  
  • 9.  
  • 10. Confocal 3d images of nuclei from nonapoptotic (A) and apoptotic (B) cells stained with PI A B
  • 12. Ca +2 Ca +2 Bad Raf-1 P Bad Bad Bad PT Pore Bax Conductance Pore Bag-1 AIF Bax Bax Bax Bax Bax Bax Bax CYTOCHROME C RELEASE CASPASE-9 APAF-1 (CED-4) OLIGOMERIZATION of APAF-1 ATP, dATP ACTIVATION OF CASPASE-9 “ Initiator caspase ” CARD ACTIVATED CASPASE-9 CASPASES-3,-6,-7 ACTIVATION OF CASPASES INTRACELLULAR DEATH SIGNALS nucleus PARP PARP p53 Smac/DIABLO IAP Smac/DIABLO IAP Bcl-2 Bcl-X L Bcl-X L Bcl-2 Bcl-2 Bcl-2 Bcl-2
  • 13. Main pathways of apoptosis Execution Cleavage of Apoptosis Regulators Cleavage of Housekeeping Proteins DNA Fragmentation Signals Death ligands (TNF, TRAIL) Internal cell stress, DNA damage Death Receptors Cytochrome C Release Caspase a ctivator FADD Apaf-1 Bid Initiator c aspase Caspase-8, Caspase-10 Caspase-9 Effector c aspase Caspase-3, Caspase-6 or Caspase-7
  • 14. Features of apoptosis measured by flow or laser scanning cytometry Plasma membrane Change in permeability Change in asymmetry of phosphatidylserine Nucleus Chromatin condensation Nuclear fragmentation DNA fragmentation Organelles Change in mitochondrial membrane potential (  m ) Other features Caspase activation PARP cleavage Ser -proteases activation Transglutaminase 2 activation
  • 15. LINKER DNA Apoptosis-induced DNA fragmentation HISTONE OCTAMER (NUCLEOSOME CORE) DNA ELECTROPHORESIS Distance between cuts = multiplicity of 200 base pairs 200 bp 400 bp 600 bp 800 bp ICAD CAD DNA cleavage
  • 16. Indirect labeling of DNA breaks dUTP -biotynylated TdT TdT avidin-FITC DNA cleavage ICAD CAD
  • 17. Apoptotic in situ DNA strand breaks
  • 18. Colocalization: DNA and DNA strand breaks
  • 19.
  • 20.
  • 21. Early event of apoptosis: translocation of Bax to mitochondria Bcl-2 Bcl-X L Caspase 9 PARP PARP nucleus Bcl-X L - Bcl 2 Bcl-2 Ca +2 Ca +2 Bad Raf-1 P Bad Bad Bad PT Pore Bax Conductance Pore p53 Caspase 3 Bag-1 Bcl-2 Bcl-2 APAF-1 AIF Cytochrome C Bax Bax Bax Bax Bax Bax Bax Bax Bax
  • 22. Bax immunofluorescence, MCF-7 cells, CPT-treated
  • 23. Translocation of Bax to mitochondria N Bax in cytoplasm and in nucleus Bax in mitochondria C (diffuse) (punctate)
  • 24. Translocation of Bax to mitochondria: Increase of maximal pixel of Bax immunofluorescence DNA Content DNA Content DNA Content CTRL CPT 24h CPT 48h 150 150 150 0 0 0 G 1 S G 2 M Bax Max Pixel G 1 S G 2 M Bax max pixel DNA content
  • 25. Dissipation of the mitochondrial trans- membrane electrochemical potential Rhodamine 123 or carbo - cyanine dyes “ Aggregate” dyes (e.g. JC-1)
  • 26. HL-60 CTRL HL-60 CPT 4h Rh 123 (rhodamine 123) Green Integral Green Integral Scatter Integral Scatter Integral
  • 27. HL-60 CTRL HL-60 CPT 4h JC-1 (“aggregate” dye) (5,5’,6,6’-tetrachloro-1,1’,3,3’-tetraethylbenzimidazolcarbocyanine iodide) Green Integral Green Integral Orange Integral Orange Integral
  • 28.
  • 31. PARP cleavage vs appearance of DNA strand breaks CPT-induced
  • 32. PARP cleavage vs appearance of DNA strand breaks TNF-induced
  • 33. PARP cleavage vs DNA strand break apperance
  • 34. PARP cleavage vs appearance of DNA strand breaks
  • 35. Is collapse of the mitochondrial potential a prerequisite for cytochrome c release ? Bcl-2 Bcl-X L Caspase 9 PARP PARP nucleus Bcl-X L - Bcl 2 Bcl-2 Ca +2 Ca +2 Bad Raf-1 P Bad Bad Bad PT Pore Bax Conductance Pore p53 Caspase 3 Bag-1 Bcl-2 Bcl-2 APAF-1 AIF Cytochrome C Bax Bax Bax Bax Bax Bax Bax Bax Bax
  • 36. Multiparameter analysis; cause - effect relationship A B A B ~100% B+ will be A+ some B+ will be A-
  • 37. Cell attributes studied supravitally Cell attributes that require cell fixation Integrity of plasma membrane Surface immuno-typing Phosphatidylserine on cell surface Transport through membrane Intracellular pH Oxidative stress (ROIs) Mitochondrial potential Level of glutathione Activation of intracellular enzymes Calcium flux and other ions Cell cycle position, DNA ploidy BrdU incorporation DNA strand breaks Chromatin condensation Activation of NF-kappa B Bax, cytochrome c translocations Translocation of other (AIF, APAF-1) molecules Caspase activation (e.g. PARP cleavage) Immunodetection of intracellular proteins Changes in cell morphology
  • 38. Strategy to detect correlation between the paramaters measured on live (mitochondrial potential) vs fixed (PARP cleavage) cells by LSC Live cells Measure  m Fix cells Measure PARP File # 1 File # 2 Merge file # 1 and # 2 Analyze the merged file
  • 39. Mitochondrial potential vs PARP cleavage
  • 40. Fl uorochrome-labeled i nhibitors of ca spasses FLICA Affinity labeling probes of caspase enzymatic center FAM FMK VEID
  • 41. INACTIVE CASPASE (ZYMOGEN) ACTIVATED CASPASE (HETERO-TETRAMER) BINDING OF FLICA prodomain A B C D FLICA Active center Active center FAM FMK VEID
  • 43. VAD CTRL CPT 3H CPT 4H VEID TNF+CHX 1h TNF+CHX 1.5h VAD CTRL
  • 44. PI - fluorescence FAM-VAD-FMK 100 0 10 4 PI - fluorescence FAM-VAD-FMK 100 0 10 4 FAM-VAD-FMK FAM-VAD-FMK 100 100 Number of cells Number of cells 0 0 Control Control 3h CPT 3h CPT D C A B Caspases activation during apoptosis induced by CPT
  • 45. Green Max Pixel Cell frequency 0 100 100 1 2 Protection of FAM-VAD-FMK binding by cell pre-exposure to z-VAD-FMK
  • 46. A B Caspases activation detected by FAM-VAD-FMK binding
  • 48. Concurrent cell staining with FAM-VAD-FMK and PI FAM-VAD-FMK fluorescence PI fluorescence
  • 49. Time (h) control 2h 3h 4h 5h A B C D B A D C Cell number (%) P I f l u o r e s c e n c e 100 0 10 4 10 4 10 4 10 4 10 4 0 2 3 4 5 100 FAM-VAD-FMK fluorescence 0 0 0 0 0 100 100 100 100 Kinetics of FAM-VAD-FMK and PI binding
  • 50. Caspase activation - cell cycle specificity Effect of TNF on HL-60 cells PI, INT FAM-VAD-FMK; MPX 0 a b 10 3 10 3 100 100 0  FAM-VAD-FMK; INT FAM-VAD-FMK; INT G 1 S G 2 /M
  • 51. A B C D Propidium Iodide FAM-VAD-FMK Distinction between apoptotic and necrotic cells based on caspases activation (FAM-VAD-FMK binding) vs exclusion of PI Ctr Parthenolide -treated HL-60 cells
  • 52. Correlation between caspase activation and Annexin V binding Annexin V, Max Pix FAM-VAD-FMK, Max Pix Annexin V, Max Pix
  • 53. Stathmo-apoptosis; arresting progress of apoptotic process Not arrested Arrested FAM-VAD-FMK fluorescence P I f l u o r e s c e n c e P I f l u o r e s c e n c e FAM-VAD-FMK fluorescence FAM-VAD-FMK fluorescence FAM-VAD-FMK fluorescence FAM-VAD-FMK fluorescence 100 100 100 100 100 0 0 0 0 0 10 4 10 4 10 4 10 4 10 4 3 % 2 % 4 % 9 % 21 % 20 % 25 % 2 % 2 % 2 % 9 % 7 % 51% 10 % 2 % 6h 3h
  • 54. Stathmo-apoptosis ARRESTED NOT ARRESTED A B C D FAM-VAD-FMK 10 4 10 4 0 Propidium iodide Control A C D P r o p i d i u m i o d i d e B FAM-VAD-FMK 10 4 10 4 0 10 4 10 4 0 10 4 10 4 0 FAM-VAD-FMK 10 4 10 4 0 TNF FLICA TNF + FLICA CPT + FLICA CPT FLICA
  • 55. FAM-VAD-FMK fluorescence 10 0 Stathmo-apoptosis Apoptotic MCF 7 cells prevented from detachment 48h 72h Control Ap-1% Ap-13% Ap-23% Ap-39% Ap-24% P I f l u o r e s c e n c e 0 0 FAM-VAD-FMK fluorescence FAM-VAD-FMK fluorescence 0 0 10 2 0 FAM -VAD -FMK fluorescence FAM-VAD-FMK fluorescence 10 2 10 2 10 2 10 2 P I f l u o r e s c e n c e 10 0 10 0 10 0 10 0
  • 56. Activation-induced apoptosis of lymphocytes Caspases activation detected by FLICA PI fluorescence FAM-VAD-FMK CTR PHA PHA+ONC A A D A B B B D D C C C A B C D
  • 57. 0 24 48 72 0 0 Time (h) 40 40 0 0 60 60 0 60 Time (h) CAI (%) CAI (%) CAI (%) Patient 1 Patient 2 Patient 3 Patient 4 0 24 48 72 0 24 48 72 0 24 48 72 0 24 48 72 Patient 5 2-CdA Control Subtracted CAI
  • 58.
  • 59. FLISP (Fluorochrome-labeled inhibitor of Ser -proteases) Labeling of active enzyme center of Ser -proteases with FLISP Asp-102 His-57 Ser-195 FAM F (Phe) CMK Imidazole Alkylated imidazole Active chymotrypsin Covalent binding of FLISP
  • 60. CPT-induced apoptosis of T-24 cells - Texas Red-FCK vs DAPI
  • 61. Propidium iodide 10 4 10 4 10 4 10 4 FFCK FFCK FLCK FLCK FFCK FLCK FFCK FLCK 100 100 100 100 100 100 100 100 0 0 0 0 Control 3h CPT Control Control Control 3h CPT 3h CPT 3h CPT Number of cells 0 0 0 0 Activation of Ser -proteases reactive with FFCK and FLCK during apoptosis of HL-60 cells induced by CPT
  • 62. SR-VAD-FMK 100 0 FFCK 0 100 r = 0.72 Activation of caspases and Ser -protease(s) ( FFCK -reactive) in HL- 60 cells 3 h after addition of CPT
  • 63. Activation of caspases and Ser-proteases SR-VAD-FMK / FFCK
  • 64. FLCK SR-VAD-FMK 100 0 100 r = 0.82 Activation of caspases and Ser -protease(s) ( FLCK -reactive) in HL- 60 cells 3 h after addition of CPT
  • 65. FAM-VAD-FMK FFCK r = 0.98 FLCK FAM-VAD-FMK r = 0.982 Correlation between activation of caspases (FAM-VAD-FMK) and Ser -proteases during apoptosis of HL-60 cells induced by CPT r = 0.986
  • 66. SR-VAD-FMK (Int) FFCK (Int) 0 100 SR-VAD-FMK (Int) FFCK (Int) 0 100 100 100 100 0 Apoptosis of HL-60 cells induced by Onconase FFCK vs SR-VAD-FMK binding Ctrl Onc
  • 67. 100 SR-VAD-FMK (Int) FLCK (Int) 0 100 100 SR-VAD-FMK (Int) FLCK (Int) 0 100 100 Apoptosis of HL-60 cells induced by Onconase FLCK vs FAM-VAD-FMK binding
  • 68. Activation of caspases and Ser-proteases during apoptosis of HL-60 cells induced by Onconase PI fluorescence FAM-VAD-FMK FFCK FLCK Ctrl Ctrl Ctrl Onc Onc Onc
  • 69. Proteins covalently reactive with FFCK and FLCK (anti-fluorescein Ab) 205 112 70 52.4 Control FFCK FFCK+TNF Control FLCK FLCK+TNF
  • 70. Brander Cancer Research Institute at NYMC, Valhalla, NY E. Bedner W. Gorczyca J. Grabarek G. Juan X. Li P. Pozarowski P. Smolewski F. Traganos Z. Darzynkiewicz Immunochemistry Technologies, Bloomington NM B.W. Lee G. Johnson
  • 71.
  • 72. A B C D * * * * * * * * TGase 2 Resistance to detergent (A,B) Fluorescein-cadaverine binding (C,D)
  • 73. SULFORHODAMINE (protein) 100 100 0 A D 100 100 0 C 100 100 0 B G 1 G 2 M S DAPI; DNA content TGase 2, cell resistance to detergent
  • 74. FL - cadaverine DNA content 100 0 100 FL - cadaverine DNA content 100 0 100 G 1 G 2 M S TGase 2; binding of fluoresceinated cadaverine
  • 75. FAM-VAD-FCK vs PI FFCK vs PI FLCK vs PI